IDEN Biotechnology S.L., today announced that has signed an agreement with Bioceres S.A., an agricultural biotechnology company[1], for the co-development and commercialization of specific wheat genetic traits. The agreement comprises a technology developed by the University of Barcelona and the University of Valencia to produce plants with resistance to low-temperature stress.
This strategic collaboration between Bioceres and IDEN Biotechnology S.L. will enable the former to develop the technology necessary to efficiently obtain low-temperature resistant varieties of wheat, one of the most important crops in the planet.
About IDEN Biotechnology:
IDEN Biotechnology is an agribiotech company with a substantial portfolio of technologies and products to increase crop yield with two business lines: crop improvement and agrobiologicals. The crop improvement area focuses on the identification and development of vegetal genes with agronomic value for the improvement of crop yield and quality, while the agrobiological area focuses on the development of biological compounds that provide higher yield and resistance. The products/ technologies are protected by a strong patent portfolio.
The Company has been very active internationally and has reached several licensing and co-development agreements with companies in USA, South America and India, among others. It is also working to strengthen the capital structure and in achieving greater key markets penetration.
More info at www.idenbiotechnology.com.
The Spanish Venture Capital Firm CRB Inverbío is the lead investor in IDEN Biotechnology.
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Investigadores del Cima Universidad de Navarra constatan que la combin...
